BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34354812)

  • 1. Pan-cancer chromatin analysis of the human vtRNA genes uncovers their association with cancer biology.
    Fort RS; Duhagon MA
    F1000Res; 2021; 10():182. PubMed ID: 34354812
    [No Abstract]   [Full Text] [Related]  

  • 2. Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6.
    Chen J; OuYang H; An X; Liu S
    PLoS One; 2018; 13(1):e0191325. PubMed ID: 29346433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth.
    Fort RS; Mathó C; Geraldo MV; Ottati MC; Yamashita AS; Saito KC; Leite KRM; Méndez M; Maedo N; Méndez L; Garat B; Kimura ET; Sotelo-Silveira JR; Duhagon MA
    BMC Cancer; 2018 Feb; 18(1):127. PubMed ID: 29394925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients.
    Helbo AS; Treppendahl M; Aslan D; Dimopoulos K; Nandrup-Bus C; Holm MS; Andersen MK; Liang G; Kristensen LS; Grønbæk K
    Genes (Basel); 2015 Oct; 6(4):977-90. PubMed ID: 26473932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the vault RNA protects cells from undergoing apoptosis.
    Amort M; Nachbauer B; Tuzlak S; Kieser A; Schepers A; Villunger A; Polacek N
    Nat Commun; 2015 May; 6():7030. PubMed ID: 25952297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vault RNA of
    Kolev NG; Rajan KS; Tycowski KT; Toh JY; Shi H; Lei Y; Michaeli S; Tschudi C
    J Biol Chem; 2019 Oct; 294(43):15559-15574. PubMed ID: 31439669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Small Non-coding Vault RNA1-1 Acts as a Riboregulator of Autophagy.
    Horos R; Büscher M; Kleinendorst R; Alleaume AM; Tarafder AK; Schwarzl T; Dziuba D; Tischer C; Zielonka EM; Adak A; Castello A; Huber W; Sachse C; Hentze MW
    Cell; 2019 Feb; 176(5):1054-1067.e12. PubMed ID: 30773316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of vault RNAs.
    Stadler PF; Chen JJ; Hackermüller J; Hoffmann S; Horn F; Khaitovich P; Kretzschmar AK; Mosig A; Prohaska SJ; Qi X; Schutt K; Ullmann K
    Mol Biol Evol; 2009 Sep; 26(9):1975-91. PubMed ID: 19491402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human vault RNA enhances tumorigenesis and chemoresistance through the lysosome in hepatocellular carcinoma.
    Ferro I; Gavini J; Gallo S; Bracher L; Landolfo M; Candinas D; Stroka DM; Polacek N
    Autophagy; 2022 Jan; 18(1):191-203. PubMed ID: 33960270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML.
    Treppendahl MB; Qiu X; Søgaard A; Yang X; Nandrup-Bus C; Hother C; Andersen MK; Kjeldsen L; Möllgård L; Hellström-Lindberg E; Jendholm J; Porse BT; Jones PA; Liang G; Grønbæk K
    Blood; 2012 Jan; 119(1):206-16. PubMed ID: 22058117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. vtRNA2-1/nc886 Produces a Small RNA That Contributes to Its Tumor Suppression Action through the microRNA Pathway in Prostate Cancer.
    Fort RS; Garat B; Sotelo-Silveira JR; Duhagon MA
    Noncoding RNA; 2020 Feb; 6(1):. PubMed ID: 32093270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
    Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
    Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential hypermethylation of the VTRNA2-1 promoter in hepatocellular carcinoma as a prognostic factor: Tumor marker prognostic study.
    Yu MC; Lee CW; Lin CH; Wu CH; Lee YS; Tsai CL; Tsai CN
    Int J Surg; 2020 Jul; 79():282-289. PubMed ID: 32417463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding 886 (
    Raitoharju E; Rajić S; Marttila S
    Epigenetics; 2024 Dec; 19(1):2332819. PubMed ID: 38525792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
    Youn A; Kim KI; Rabadan R; Tycko B; Shen Y; Wang S
    BMC Med Genomics; 2018 Nov; 11(1):98. PubMed ID: 30400878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable maternal methylation overlapping the nc886/vtRNA2-1 locus is locked between hypermethylated repeats and is frequently altered in cancer.
    Romanelli V; Nakabayashi K; Vizoso M; Moran S; Iglesias-Platas I; Sugahara N; Simón C; Hata K; Esteller M; Court F; Monk D
    Epigenetics; 2014 May; 9(5):783-90. PubMed ID: 24589629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human vault RNA1-1, but not vault RNA2-1, modulates synaptogenesis.
    Wakatsuki S; Ohno M; Araki T
    Commun Integr Biol; 2021 Apr; 14(1):61-65. PubMed ID: 33948134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-barr virus-induced expression of a novel human vault RNA.
    Nandy C; Mrázek J; Stoiber H; Grässer FA; Hüttenhofer A; Polacek N
    J Mol Biol; 2009 May; 388(4):776-84. PubMed ID: 19298825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of 5-methylcytosine alters the biogenesis of vault-derived small RNAs to coordinate epidermal differentiation.
    Sajini AA; Choudhury NR; Wagner RE; Bornelöv S; Selmi T; Spanos C; Dietmann S; Rappsilber J; Michlewski G; Frye M
    Nat Commun; 2019 Jun; 10(1):2550. PubMed ID: 31186410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human vtRNA1-1 Levels Modulate Signaling Pathways and Regulate Apoptosis in Human Cancer Cells.
    Bracher L; Ferro I; Pulido-Quetglas C; Ruepp MD; Johnson R; Polacek N
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32316166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.